Side effects - Eyes - Chronic Myeloid Leukemia - CML
"Periorbital edema occurred an average of 68+/-48 days after initiation of therapy. WHO classification of side-effects is as follows: certain: periorbital edema; probable: epiphora; possible: extraocular muscle palsy, ptosis, blepharoconjunctivitis; unlikely: glaucoma, papilledema, retinal hemorrhage, photosensitivity, abnormal vision, and increased intraocular pressure. Periorbital edema and epiphora are the two most common ocular side-effects related to imatinib mesylate therapy. "
ARTICLES
Visual Disturbance as the first Symptom of Chronic Myeloid Leukemia
December 2011, Middle east African Journal of Ophthalmology
Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: A review
July 9, 2021, Survey of Ophthamology
Chronic myelogenous leukemia presenting as central retinal vein occlusion.
June 22, 2020, Taylor and Francis Online
Ocular side effects of systemically administered chemotherapy
Feb 04, 2020, Uptodate
Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature
2015, Hindawi
Bilateral proliferative retinopathy as the initial presentation of chronic myeloid leukemia
2013, MEAJO
Visual Disturbance as the first Symptom of Chronic Myeloid Leukemia
December 2011, NCBI
Roth spots in chronic myelogenous leukemia
September 19, 2011, cmaj
Time-specific blockade of PDGFR with Imatinib (Glivec) causes cataract and disruption of lens fiber cells in neonatal mice.
December 23, 2010, PubLMed
Sudden unilateral visual loss as an initial presentation of chronic myelogenous leukemia
March 30. 2010, Dovepress
Optic disc edema as a possible complication of Imatinib mesylate (Gleevec).
August 2008, PubLmed
Ocular side-effects associated with imatinib mesylate (Gleevec)
August 2003, PubLMed
Isolated optic nerve involvement in chronic myeloid leukemia
1992, ResearchGate
Visual Disturbance as the first Symptom of Chronic Myeloid Leukemia
December 2011, Middle east African Journal of Ophthalmology
Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: A review
July 9, 2021, Survey of Ophthamology
Chronic myelogenous leukemia presenting as central retinal vein occlusion.
June 22, 2020, Taylor and Francis Online
Ocular side effects of systemically administered chemotherapy
Feb 04, 2020, Uptodate
Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature
2015, Hindawi
Bilateral proliferative retinopathy as the initial presentation of chronic myeloid leukemia
2013, MEAJO
Visual Disturbance as the first Symptom of Chronic Myeloid Leukemia
December 2011, NCBI
Roth spots in chronic myelogenous leukemia
September 19, 2011, cmaj
Time-specific blockade of PDGFR with Imatinib (Glivec) causes cataract and disruption of lens fiber cells in neonatal mice.
December 23, 2010, PubLMed
Sudden unilateral visual loss as an initial presentation of chronic myelogenous leukemia
March 30. 2010, Dovepress
Optic disc edema as a possible complication of Imatinib mesylate (Gleevec).
August 2008, PubLmed
Ocular side-effects associated with imatinib mesylate (Gleevec)
August 2003, PubLMed
Isolated optic nerve involvement in chronic myeloid leukemia
1992, ResearchGate
